MedTrace Logo

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

NCT03847441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-04-02

No results posted yet for this study

Summary

Alopecia Areata is a common condition. This study investigated the efficacy of calcipotriol versus Narrow Band Ultraviolet B in treatment of Alopecia areata and their effects on serum vitamin D3 levels.

Conditions

Interventions

DRUG

Calcipotriol

Calcipotriol ointment (0.005%)

DEVICE

Narrow Band UVB

NB-UVB (311nm) phototherapy

DIAGNOSTIC_TEST

vitamin D3 level

vitamin D3 (ng/ml)

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847441 on ClinicalTrials.gov